There is no evidence that lab-grown meat, also called cultivated meat, causes cancer. The concern stems from the fact that producing cultivated meat requires cells that can divide rapidly and repeatedly, a trait that overlaps superficially with how cancer cells behave. But the overlap is shallow: both the U.S. Food and Drug Administration (FDA) and the Food and Agriculture Organization of the United Nations (FAO) have expressed skepticism that eating these cells poses a cancer risk, and no case of cancer transmitted through eating cells from another animal has ever been documented. The real story is more nuanced than either the scare headlines or the reassurances suggest.
Where the Cancer Concern Comes From
To make cultivated meat at any meaningful scale, producers need cells that keep dividing far beyond what normal animal cells do. In a lab dish, most animal cells hit a natural limit on how many times they can replicate before they stop dividing and enter a state called senescence. This limit is a problem for anyone trying to grow enough muscle or fat tissue to fill a bioreactor, let alone stock a grocery shelf. The workaround is to create “immortalized” cell lines that bypass that replication ceiling and can, in theory, keep growing indefinitely.
The word “immortalized” is what trips alarm bells. Cancer cells are also immortalized in the sense that they have escaped normal growth limits. Both processes can involve some of the same biological machinery, such as boosting the activity of an enzyme called telomerase, which maintains the protective caps on chromosomes and prevents the cell from aging out of the replication cycle. Because of this overlap, critics have asked a reasonable question: if these cells are engineered to behave more like cancer, could eating them give you cancer?
Immortalized Cells Are Not Cancer Cells
The distinction matters and is not just semantic. A cancer cell has acquired a whole suite of dysfunctional traits beyond unlimited growth. It evades the immune system, resists programmed cell death, triggers new blood vessel formation to feed itself, becomes genetically unstable, and can invade surrounding tissues and spread to distant organs. An immortalized cell line made for cultivated meat production has been engineered or selected for one narrow trait: the ability to keep dividing. The other hallmarks of cancer are not just absent but would actually be counterproductive for meat production, because they make cells unpredictable and hard to control in a manufacturing process.1The Good Food Institute. Cell line development and utilisation trends in the cultivated meat industry
Researchers have several ways to immortalize cells for cultivated meat. Some involve targeted genetic changes, like increasing the expression of specific proteins that regulate cell division. Others rely on spontaneous immortalization, where cells in long-term culture occasionally break through their replication limits on their own without any deliberate genetic engineering. A recent study demonstrated this in bovine fibroblasts: after roughly 400 days in culture and about 240 rounds of cell division, the cells activated telomerase and resolved their own telomere shortening, producing stable immortalized lines without triggering the tumor-suppressor pathways that would be activated in cancer.2PubMed. Spontaneous immortalization of bovine fibroblasts following long-term expansion offers a non-transformed cell source for cultivated beef In other words, the cells found their own path to indefinite growth while remaining fundamentally non-cancerous.
This is the core point that gets lost in the public debate: while all cancer cells are immortalized, not all immortalized cells are cancerous. The relationship runs in one direction, not both.1The Good Food Institute. Cell line development and utilisation trends in the cultivated meat industry
Could Eating These Cells Trigger Cancer in Your Body?
Even setting aside the distinction between immortalized and cancerous, there is a more fundamental reason the fear does not hold up: your digestive system destroys cells. When you eat any food containing cells, whether it is a steak, a salad, or cultivated meat, your stomach acid and digestive enzymes break those cells apart into their molecular components: amino acids, fatty acids, sugars, and nucleotides. A cell’s ability to divide is a property of its intact, living machinery. Once that machinery has been disassembled in your gut, it cannot cause anything to replicate. You do not absorb whole, functional cells from your food.
This applies equally to any hypothetical scenario where actual cancer cells ended up in a food product. There are no documented cases of cancer being transmitted through the ingestion of cancerous cells or tissues from another species.1The Good Food Institute. Cell line development and utilisation trends in the cultivated meat industry Cancer is not a pathogen that can jump from one organism to another through the digestive tract. Your immune system and your digestive processes are both working against that possibility.
Growth Factors in the Culture Medium
A more scientifically grounded concern involves the growth factors used to feed cultivated meat cells during production. Cells in a bioreactor need signaling molecules to tell them when to divide and when to mature into muscle or fat. One commonly used growth factor is FGF-2 (fibroblast growth factor 2), which stimulates cell proliferation. Since some growth factors have been loosely associated with cell growth in cancer biology, it is fair to ask whether residual growth factors in the final meat product could affect human biology.
The practical answer is that very little of these growth factors survives the production process. Unmodified FGF-2 is chemically unstable at the temperatures used in cell culture. At body temperature, less than five percent of the initial concentration remains after just one day, even without any cells present to absorb it. By the time cultivated meat is harvested, the residual FGF-2 levels are likely no higher than what you would find in a comparable cut of conventional meat.3Comprehensive Reviews in Food Science and Food Safety. A review on the safety of growth factors commonly used in cultivated meat production Conventional meat contains naturally occurring growth factors too; they are a normal part of animal tissue biology.
How Conventional Meat Actually Links to Cancer
It is worth stepping back and noting what the actual evidence-based cancer risks from meat look like, because they have nothing to do with cell immortalization. The International Agency for Research on Cancer classified processed meat as a Group 1 carcinogen and red meat as a Group 2A probable carcinogen, based on links to colorectal cancer and other malignancies. The mechanisms behind those links are well studied and specific to how conventional meat is produced, processed, and cooked.
The main pathways involve:
- Heme iron: Abundant in red meat, heme iron promotes the formation of N-nitroso compounds in the gut, which are directly genotoxic and can damage DNA. It also drives oxidative stress and supports the growth of certain gut bacteria implicated in colorectal cancer.4PubMed Central. Comprehensive Review of Red Meat Consumption and the Risk of Cancer
- Heterocyclic amines (HCAs): Formed when meat is cooked at high temperatures, these compounds are converted in the body into reactive forms that bind to DNA. When fed to rodents, HCAs have caused cancers in multiple organs including the colon, breast, and prostate.5PubMed. Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish
- Polycyclic aromatic hydrocarbons (PAHs): Also generated during high-temperature cooking, especially grilling or smoking, these are recognized carcinogens.6PubMed. Mechanisms Linking Colorectal Cancer to the Consumption of (Processed) Red Meat: A Review
- Gut microbiome effects: Red meat consumption shapes the colonic microbial environment in ways that promote inflammation. Specific bacteria, including certain Fusobacterium species, appear to play a role in colorectal carcinogenesis and are influenced by diet.7PubMed. Epidemiology, Molecular Mechanisms, and Clinical Trials: an Update on Research on the Association Between Red Meat Consumption and Colorectal Cancer
Cultivated meat sidesteps some of these mechanisms by design. Because the cells are grown in a controlled environment rather than taken from a slaughtered animal, the final product does not go through the same processing steps (curing, smoking) that generate nitrites and PAHs in processed meats. Whether cultivated meat would still contain heme iron in similar concentrations is an open question that depends on how the cells are differentiated and what the final product composition looks like. HCA and PAH formation would still depend on how a consumer cooks the meat at home, since those compounds are a function of cooking temperature and method, not the meat’s origin.
Manufacturing Hazards and Bioreactor Safety
If there is a legitimate area of caution around cultivated meat and health, it probably lies not in cell biology but in manufacturing. Cultivated meat is produced in bioreactors, large steel vessels that maintain the temperature, oxygen levels, and nutrient supply that cells need to grow. Many bioreactors use single-use plastic bags as internal liners, and these plastics can leach chemical compounds into the culture medium. In the biopharmaceutical industry, which has used similar equipment for decades, researchers identified a compound called bDtBPP (bis(2,4-di-tert-butylphenyl)-phosphate) that leaches from certain plastic films and inhibits cell growth.8PubMed. Improvements in single-use bioreactor film material composition leads to robust and reliable Chinese hamster ovary cell performance
Testing of bioreactor bags from multiple vendors has found that while newer generations of films have substantially reduced leachable compounds, related chemicals like DtBP and TBPP-ox were still detected across all bags tested in one study.9PubMed. Monitoring leachables from single-use bioreactor bags for mammalian cell culture by dispersive liquid-liquid microextraction followed by ultra high performance liquid chromatography quadrupole time of flight mass spectrometry These findings come from the pharmaceutical world, where leachables are already tightly regulated because the products are injected into patients. Cultivated meat would pass through the digestive system rather than being injected, which provides an additional barrier, but the industry will need to demonstrate that any residual leachables in the final product fall well within safe limits for food.
Scaffolds are another component worth mentioning. To give cultivated meat the three-dimensional structure of real muscle tissue rather than just a paste of cells, producers grow cells on scaffolding materials. These scaffolds must either break down completely during production or be edible themselves, and any breakdown products must be nontoxic for repeated consumption.10PubMed Central. Scaffolding Biomaterials for 3D Cultivated Meat: Prospects and Challenges Common scaffold materials include plant-based proteins and polysaccharides, but the long-term safety data for consuming these in the specific forms and concentrations used in cultivated meat is still accumulating.
How Regulators Are Approaching Safety
Cultivated meat is not unregulated, though the regulatory landscape is still developing. In the United States, the FDA and USDA share oversight under a formal agreement established in 2019. The FDA handles everything from cell collection and banking through cultivation, while the USDA’s Food Safety and Inspection Service takes over at processing, packaging, and labeling for meat and poultry products.11PubMed Central. Cell-Based Meat Safety and Regulatory Approaches: A Comprehensive Review In 2023, two companies (UPSIDE Foods and GOOD Meat) received clearance from the FDA to sell cultivated chicken in the U.S., marking the first approvals of their kind.
In the European Union, cultivated meat falls under the Novel Foods Regulation, and the European Food Safety Authority (EFSA) conducts a thorough safety assessment before any product can reach the market. That assessment covers microbiological safety, chemical hazards, allergenicity, and a comparison of the nutritional profile to conventional meat.11PubMed Central. Cell-Based Meat Safety and Regulatory Approaches: A Comprehensive Review Singapore was the first country to approve cultivated meat for sale, back in 2020.
On the specific question of cell line safety, regulators expect producers to demonstrate that their cell lines are genetically stable, not tumorigenic, and well-characterized. Cells can be tested using assays for potential tumorigenicity, genetic stability, and chromosomal integrity to monitor and guard against genetic drift over time.12PubMed Central. Global Insights into Cultured Meat: Uncovering Production Processes, Potential Hazards, Regulatory Frameworks, and Key Challenges—A Scoping Review Pre-market safety dossiers from companies like UPSIDE Foods and Vow Group are publicly available and outline the quality control processes used to ensure cell bank safety at commercial scales.13Nature Food. A risk-based approach can guide safe cell line development and cell banking for scaled-up cultivated meat production
The Challenge of Long-Term Data
The honest caveat in all of this is that cultivated meat is extraordinarily new as a food product. The first regulatory approval came only in 2020, and virtually no one has been eating it regularly for more than a few years. Long-term epidemiological data, the kind that links conventional red meat to colorectal cancer across decades of population-level observation, simply does not exist for cultivated meat and will not exist for a long time. The safety assessments performed so far are based on compositional analysis, toxicology testing, and reasoning from what we know about cell biology and digestion. Those are reasonable tools, but they are not the same as watching what happens to a population over 20 or 30 years of regular consumption.
That said, the absence of long-term data is not the same as evidence of harm. Every novel food faces this same limitation when it first enters the market. The question is whether the theoretical risk pathways are plausible enough to warrant concern, and on the cancer question specifically, the pathways people worry about (immortalized cells turning your cells cancerous) do not hold up under scrutiny of how digestion actually works.
How the Nutritional Profile Compares
Cancer risk aside, one thing potential consumers are curious about is whether cultivated meat is nutritionally similar to conventional meat. The answer appears to be: close, but not identical. An analysis of cultivated chicken meat produced without animal serum found that, compared to conventional chicken, the lab-grown version had lower protein content and lower levels of most essential amino acids, as well as less magnesium and vitamin B3. On the other hand, it contained higher levels of total fat, saturated fatty acids, cholesterol, and several vitamins and minerals including calcium, iron, potassium, selenium, zinc, and vitamins A, B5, and B6.14Journal of Food Composition and Analysis. Assessment of the potential nutritional value of cell-cultured chicken meat in light of European dietary recommendations
These differences reflect the current state of production methods rather than any inherent limitation. Because the nutrient profile of cultivated meat is shaped by the culture medium and growth conditions, producers can theoretically adjust it. Researchers have proposed that cultivated meat could be enriched with health-beneficial fatty acids like omega-3s and produced with reduced saturated fat content, essentially designing a nutritional profile rather than accepting whatever nature provides.15PubMed Central. Cultured Meat Reformulation: Health Potential and Sustainable Food Challenges-Narrative Review Whether that theoretical potential translates into commercial products at competitive prices is another question entirely, and one that the industry has not yet answered.
Why This Myth Sticks Around
The “lab-grown meat is cancer” narrative persists for a few reasons that go beyond simple misunderstanding. For one, the biology is genuinely confusing. The genes and proteins involved in cell immortalization do overlap with some of those involved in cancer, and explaining why that overlap does not translate into a food safety risk requires a level of nuance that social media does not reward. The word “immortalized” itself sounds sinister in a way that “extended cell lifespan” does not, and opponents of cultivated meat have exploited that connotation effectively.
There is also a broader cultural distrust of “lab food” that makes cancer claims land harder than they otherwise would. People who already feel uneasy about eating something grown in a bioreactor are primed to believe the worst, and a claim that cultivated meat is literally made of cancer cells confirms their intuition that this technology is unnatural and dangerous. The fact that the claim contains a grain of truth (the cells really are modified to divide indefinitely, and some of the same molecular pathways really are involved in cancer) makes it harder to debunk than a claim with no factual basis at all.
Researchers in the field have acknowledged that the use of true cancer cells could theoretically offer high proliferation rates and unlimited growth for meat production, but have pointed out that this would come with “substantial downsides in the form of unstable cell phenotypes that would make designing a reliable bioprocess highly difficult.”1The Good Food Institute. Cell line development and utilisation trends in the cultivated meat industry In other words, even if safety were not a concern, cancer cells would make bad raw material for food manufacturing. The incentive structure pushes producers toward stable, predictable cells, not chaotic cancerous ones.
The industry’s bigger unresolved challenges have nothing to do with cancer. Scaling production to compete on price with conventional meat, reducing energy consumption, eliminating fetal bovine serum from culture media, achieving the texture and flavor consumers expect, and navigating a patchwork of international regulations are all formidable obstacles. Whether cultivated meat succeeds commercially will depend on solving those problems, not on whether the cancer myth can be put to rest, though addressing it clearly certainly does not hurt.